Study Group: CPAP Device Prescribers (US)

Council Members in this Study Group: 49

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Daniel Wynn, Director, Clinical Research, CONSULTANTS IN NEUROLOGY LTDDaniel Wynn

Director, Clinical Research
CONSULTANTS IN NEUROLOGY LTD
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Daniel Wynn, MD, FACN, FAASM, is the Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 130 clinical trials in...

18 news post(s)
1 event(s)
James Marquardt

Chief Executive Officer & Owner
MARIN DIAGNOSTICS INC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

James Marquardt, RCP, PSGT, is the Chief Executive Officer and Owner of Marin Diagnostics Inc in California, since August 1997. After completing medical training and a year of corporate training, Mr. Marquardt became the Administrative Director for the...

David Claman, Director, UNIVERSITY OF CALIFORNIA, SAN FRANCISCODavid Claman

Director
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

David Claman, MD, is Director of the UCSF Medical School Sleep Disorders Center. He has experience with all forms of sleep testing, including home sleep studies for sleep apnea, and actigraphy for insomnia. Dr. Claman completed a residency in Internal...

1 event(s)
Warren Botnick

President
PSS Clinical Research
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Warren Botnick, MD, FCCP, DABSM, is a Partner at Pulmonary and Sleep Specialists in Decatur, Georgia, since March 2003. He is Director of Critical Care Unit and Chief of Medicine at DeKalb Medical Center, Medical Director of Southern Sleep Technologies,...

5 news post(s)
2 event(s)
Join this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Laboratory, Independent
  • Medical Device/Supplies Distributor
  • Non-Academic Community Hospital or Clinic

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Director
  • Physician - Division Head
  • President
  • Medical Director
  • Partner

Related Study Groups

Study Group Name No. Members
Pulmonologists (US) 771
Physicians who Treat Asthma (US) 681
Distributors of Durable Medical Equipments 51
Prescribers of Aralast NP (US) 16
Psychiatrists 1657
Physicians who Treat Chronic Sinusitis (US) 143
Pain Physicians (US) 569
Asmanex Twisthaler Prescribers (US) 19

GLG Live Meetings with this Study Group's Leading Experts (?)

September 25, 2008 | Palo Alto

GLG Seminar: (Palo Alto) Sleep Disorders

June 14, 2006 | Boston

GLGi: Sleep Disorders: The Global Market for Devices and Pharmacologic Treatments

June 14, 2006 | New York

GLGi: Sleep Disorders: The Global Market for Devices and Pharmacologic Treatments

Teleconference: Multiple Sclerosis - Novel Therapies Under Development (3:30 PM EST/12:30 PM PST)

12/2/2010